人白介素-11

Records for this ingredient, by country (identity only).

ATC L03AC · 1 markets · 19 records

人白介素-11 1 markets · 19 records Forms
Filters
MarketCN 19

CN 19 records · 5 shown of 5 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 1.5 mg per mL / per unit basis not statedinjection吉巨芬人白介素-11巨和粒、特尔康、百杰依、迈格尔
  • 3 mg per mL / per unit basis not statedinjection吉巨芬人白介素-11巨和粒、特尔康
  • 1 mg per mL / per unit basis not statedinjection巨和粒人白介素-11特尔康
  • 0.75 mg per mL / per unit basis not statedinjection吉巨芬人白介素-11迈格尔
  • 2 mg per mL / per unit basis not statedinjection特尔康人白介素-11

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.